Valeritas Aktie - VLRX

Professionelle Tools für Privatanleger.

Premium

Current Price

0,2568

Gebot

0,25

Fragen

0,2549

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,2568

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees Company and Subsidiaries Commence Voluntary Chapter 11...

Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...

BRIDGEWATER, N.J., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...

BRIDGEWATER, N.J., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

BRIDGEWATER, N.J., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Announces Third Quarter 2019 Financial Results

BRIDGEWATER, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

BRIDGEWATER, N.J., Oct. 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

BRIDGEWATER, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...

BRIDGEWATER, N.J., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...

BRIDGEWATER, N.J., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...

BRIDGEWATER, N.J., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

VLRX - Frequently Asked Questions (FAQ)

What is the current Valeritas share price?

The current share price of Valeritas is US$ 0,2568

What is the 1 year trading range for Valeritas share price?

Valeritas has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
STAIScanTech AI Systems Inc	US$ 4,04 (97,07%)	101,91M
KWEKWESST Micro Systems Inc	US$ 0,8273 (77,15%)	212,98M
EFOIEnergy Focus Inc	US$ 2,0289 (57,28%)	34,78M
WGSGeneDx Holdings Corporation	US$ 106,70 (39,75%)	2,23M
CGBSCrown LNG Holdings Ltd	US$ 0,406 (39,71%)	55,94M
INLFINLIF Limited	US$ 2,73 (-83,28%)	5,25M
BPTHBio Path Holdings Inc	US$ 0,20 (-68,41%)	4,48M
SEPNSepterna Inc	US$ 4,7301 (-63,50%)	4,28M
PTPIPetros Pharmaceuticals Inc	US$ 0,1337 (-54,37%)	20,94M
RSLSReShape Lifesciences Inc	US$ 1,11 (-52,36%)	4,41M
ADTXAditxt Inc	US$ 0,095 (35,71%)	426,04M
KWEKWESST Micro Systems Inc	US$ 0,8273 (77,15%)	212,98M
PRPHProPhase Labs Inc	US$ 0,45 (38,46%)	160,21M
INTCIntel Corporation	US$ 25,93 (9,87%)	122,44M
NVDANVIDIA Corporation	US$ 140,195 (0,97%)	104,59M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Valeritas Holdings Inc (VLRX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

VLRX Neueste Nachrichten

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...

Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

Valeritas Announces Third Quarter 2019 Financial Results

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...

Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...

VLRX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Valeritas Holdings Inc (VLRX) Börsenkurse

Valeritas Holdings Inc (VLRX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

VLRX Neueste Nachrichten

Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarte...

Valeritas Presents Positive h-Patch™ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 A...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

Valeritas Announces Third Quarter 2019 Financial Results

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch™ Wearable Device in Preclin...

Valeritas Presents Positive h-Patch™ Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer’s Disease...

Valeritas Announces Poster Presentation of Preclinical h-Patch™ Cannabidiol (CBD) Study at the American Epilepsy Society's ...

VLRX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS